P1021 / FTC + EFV + ddI Didanosine QD in Naive Children

An Open-Label Study to Evaluate the Safety, Tolerance, Antiviral Activity and Pharmacokinetics of Emtricitabine in Combination with Efavirenz and Didanosine in a Once-Daily Regimen in HIV-Infected Antiretroviral-Naïve or Very Limited Antiretroviral-Exposed Pediatric Subjects